Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Methodological approach to Microscopic Colitis diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lymphomas of the head and neck region: an update

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ana Velasco
  • Fatma Tokat
  • Jesper Bonde
  • Nicola Trim
  • Elisabeth Bauer
  • Adam Meeney
  • Wendy de Leng
  • George Chong
  • Véronique Dalstein
  • Lorand L Kis
  • Jon A Lorentzen
  • Snjezana Tomić
  • Keeley Thwaites
  • Martina Putzová
  • Astrid Birnbaum
  • Romena Qazi
  • Vanessa Primmer
  • Barbara Dockhorn-Dworniczak
  • Javier Hernández-Losa
  • Fernando A Soares
  • Asaf A Gertler
  • Michal Kalman
  • Chris Wong
  • Dirce M Carraro
  • Ana C Sousa
  • Rui M Reis
  • Stephen B Fox
  • Matteo Fassan
  • Marie Brevet
  • Sabine Merkelbach-Bruse
  • Richard Colling
  • Elizabeth Soilleux
  • Ryan Yee Wei Teo
  • Nicky D'Haene
  • Serge Nolet
  • Ari Ristimäki
  • Timo Väisänen
  • Caroline Chapusot
  • Afsaneh Soruri
  • Tina Unger
  • Johanna Wecgowiec
  • Michele Biscuola
  • Milo Frattini
  • Anna Long
  • Paulo V Campregher
  • Xavier Matias-Guiu
Vis graf over relationer

Microsatellite instability (MSI) is present in 15-20% of primary colorectal cancers. MSI status is assessed to detect Lynch syndrome, guide adjuvant chemotherapy, determine prognosis, and use as a companion test for checkpoint blockade inhibitors. Traditionally, MSI status is determined by immunohistochemistry or molecular methods. The Idylla™ MSI Assay is a fully automated molecular method (including automated result interpretation), using seven novel MSI biomarkers (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, SULF2) and not requiring matched normal tissue. In this real-world global study, 44 clinical centers performed Idylla™ testing on a total of 1301 archived colorectal cancer formalin-fixed, paraffin-embedded (FFPE) tissue sections and compared Idylla™ results against available results from routine diagnostic testing in those sites. MSI mutations detected with the Idylla™ MSI Assay were equally distributed over the seven biomarkers, and 84.48% of the MSI-high samples had ≥ 5 mutated biomarkers, while 98.25% of the microsatellite-stable samples had zero mutated biomarkers. The concordance level between the Idylla™ MSI Assay and immunohistochemistry was 96.39% (988/1025); 17/37 discordant samples were found to be concordant when a third method was used. Compared with routine molecular methods, the concordance level was 98.01% (789/805); third-method analysis found concordance for 8/16 discordant samples. The failure rate of the Idylla™ MSI Assay (0.23%; 3/1301) was lower than that of referenced immunohistochemistry (4.37%; 47/1075) or molecular assays (0.86%; 7/812). In conclusion, lower failure rates and high concordance levels were found between the Idylla™ MSI Assay and routine tests.

OriginalsprogEngelsk
TidsskriftVirchows Archiv : an international journal of pathology
ISSN0945-6317
DOI
StatusE-pub ahead of print - 10 nov. 2020

ID: 61229470